Back to Search
HAROLD SLOCUM, MD
MD
Family Medicine Physician
NPI: 1558350033Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
35060586(OH)
Research & Publications (20)
Hypoxia-specific drug tirapazamine does not abrogate hypoxic tumor cells in combination therapy with irinotecan and methylselenocysteine in well-differentiated human head and neck squamous cell carcinoma a253 xenografts.
PMID 18670644·Neoplasia·2008
7-preclinical
Potential tumor markers for human gastric cancer: an elevation of glycan:sulfotransferases and a concomitant loss of alpha1,2-fucosyltransferase activities.
PMID 17492468·J Cancer Res Clin Oncol·2007
8-other
The mechanism of methylselenocysteine and docetaxel synergistic activity in prostate cancer cells.
PMID 17041098·Mol Cancer Ther·2006
7-preclinical
Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47phox-/- mouse model of chronic granulomatous disease.
PMID 16436692·Antimicrob Agents Chemother·2006
7-preclinical
S-phase modulation by irinotecan: pilot studies in advanced solid tumors.
PMID 15947933·Cancer Chemother Pharmacol·2005
3-trial
Differential expression of survivin-2B and survivin-DeltaEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC).
PMID 15936846·Lung Cancer·2005
8-other
Image analysis using the fluorochromasia assay to quantify tumor drug sensitivity.
PMID 15901936·Methods Mol Med·2005
7-preclinical
Lack of microvessels in well-differentiated regions of human head and neck squamous cell carcinoma A253 associated with functional magnetic resonance imaging detectable hypoxia, limited drug delivery, and resistance to irinotecan therapy.
PMID 15585636·Clin Cancer Res·2004
7-preclinical
Upregulation of the tissue inhibitor of metalloproteinase-1 protein is associated with progression of human non-small-cell lung cancer.
PMID 15249585·J Clin Oncol·2004
8-other
Definition of a region of loss of heterozygosity at chromosome 11q23.3-25 in head and neck squamous cell carcinoma using laser capture microdissection technique.
PMID 15163007·Diagn Mol Pathol·2004
8-other
Therapeutic synergy between irinotecan and 5-fluorouracil against human tumor xenografts.
PMID 14871992·Clin Cancer Res·2004
7-preclinical
Altered E-cadherin and epidermal growth factor receptor expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and immunohistochemistry.
PMID 14739904·Mod Pathol·2004
8-other
HER-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer: a study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridization.
PMID 14639106·Diagn Mol Pathol·2003
8-other
A new nonlinear mixture response surface paradigm for the study of synergism: a three drug example.
PMID 14529372·Curr Drug Metab·2003
8-other
Thymidine and hypoxanthine protection patterns of the folic acid-enhanced synergies for combinations of trimetrexate plus a polyglutamylatable inhibitor of purine or thymidylate synthesis against human ileocecal HCT-8 cells.
PMID 12851689·Int J Oncol·2003
4-observational
Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study.
PMID 12827614·Hum Pathol·2003
8-other
Loss of cables protein expression in human non-small cell lung cancer: a tissue microarray study.
PMID 12612882·Hum Pathol·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 319 W LORAIN ST
OBERLIN, OH 44074 - Phone
- (440) 988-1009
Quick Facts
- NPI
- 1558350033
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile